Advertisement

Endocarditis

  • Syed Wamique Yusuf
  • Steven C. Napierkowki
  • Jose Banchs
  • Javier A. Adachi
  • Saamir A. Hassan
Chapter

Abstract

Endocarditis, defined as infection of the native or prosthetic heart valve, endocardial surface or an intracardiac device, occurs worldwide and though uncommon, can be associated with considerable morbidity and mortality.

In this chapter we present some common clinical cases and discuss the treatment options.

Keywords

Endocarditis Valve Prosthetic valve Cardiac devices 

References

  1. 1.
    Edoute Y, Haim N, Rinkevich D, et al. Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med. 1997;102:252–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Yusuf SW, Ali SS, Swafford J, et al. Culture-positive and culture-negative endocarditis in patients with cancer: a retrospective observational study, 1994-2004. Medicine. 2006;85:86–94.CrossRefPubMedGoogle Scholar
  3. 3.
    RW T, Parkas DK, Friis S, et al. Endocarditis and risk of cancer: a Danish nationwide cohort study. Am J Med. 2013;126:58–67.CrossRefGoogle Scholar
  4. 4.
    Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumor. Colorectal Dis. 2010;12:164–71.CrossRefPubMedGoogle Scholar
  5. 5.
    Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387:882–93.CrossRefPubMedGoogle Scholar
  6. 6.
    Vanassche T, Peetermans WE, Herregods MC, Herijgers P, Verhamme P. Antithrombotic therapy in infective endocarditis. Expert Rev Cardiovasc Ther. 2011;9(9):1203–19.CrossRefPubMedGoogle Scholar
  7. 7.
    Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:6855.CrossRefGoogle Scholar
  8. 8.
    Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med. 2007;357:470.CrossRefPubMedGoogle Scholar
  9. 9.
    Gross L, Friedberg CK. Nonbacterial thrombotic endocarditis. Classification and general description. Arch Intern Med. 1936;58:620–40.CrossRefGoogle Scholar
  10. 10.
    Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J. 1987;113:774–84.CrossRefGoogle Scholar
  11. 11.
    Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. Antithrombotic and thrombolytic therapy for valvular heart disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e576S–600S.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cabell CH, Jollis JG, Gail EP, Corey R, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162:90–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Leither MD, Shroff GR, Ding S, et al. Long term survival of dialysis patients with bacterial endocarditis undergoing valvular replacement surgery in the United States. Circulation. 2013;128:344–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–4.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70:325–59.CrossRefPubMedGoogle Scholar
  16. 16.
    Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(44):3075–128.CrossRefPubMedGoogle Scholar
  17. 17.
    Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. A scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.CrossRefPubMedGoogle Scholar
  18. 18.
    Heiro M, Nikoskelainen J, Engblom E, et al. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med. 2000;160(18):2781–7. doi:10.1001/archinte.160.18.2781.CrossRefPubMedGoogle Scholar
  19. 19.
    Loughrey PB, Armstrong D, Lockhart CJ. Classical eye signs in bacterial endocarditis. QJM. 2015;108(11):909–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Servy A, Valeyrie-Allanore L, Alla F, et al. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol. 2014;150(5):494–500.CrossRefPubMedGoogle Scholar
  21. 21.
    Cunha BA, Gill MV, Lazar JM. Acute infective endocarditis. Diagnostic and therapeutic approach. Infect Dis Clin North Am. 1996;10:811–34.CrossRefPubMedGoogle Scholar
  22. 22.
    Thomas P, Allal J, Bontoux D, et al. Rheumatologic manifestations of infective endocarditis. Ann Rheum Dis. 1984;43:716–20.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Yusuf SW, Sharma J, Durand JB, Banchs J. Endocarditis and myocarditis: a brief review. Expert Rev Cardiovasc Ther. 2012;10(9):1153–64.CrossRefPubMedGoogle Scholar
  24. 24.
    Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O. Fungal endocarditis: current challenges. Int J Antimicrob Agents. 2014;44(4):290–4. doi:10.1016/j.ijantimicag.2014.07.003. (//www.sciencedirect.com/science/article/pii/S0924857914002349). ISSN: 0924-8579.CrossRefPubMedGoogle Scholar
  25. 25.
    Lefort A, Chartier L, Sendid B, Wolff M, Mainardi J-L, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18(4):E99–109. doi:10.1111/j.1469-0691.2012.03764.x. (//www.sciencedirect.com/science/article/pii/S1198743X1461466X). ISSN: 1198-743X.CrossRefPubMedGoogle Scholar
  26. 26.
    Tacke D, Koehler P, Cornely OA. Fungal endocarditis. Curr Opin Infect Dis. 2013;26:501–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am Heart J. 1989;117(5):1140–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Heydari AA, Safari H, Sarvhad MR. Isolated tricuspid valve endocarditis. Int J Infect Dis. 2009;13:e109–11.CrossRefPubMedGoogle Scholar
  29. 29.
    Forrest GN, et al. Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect. 2011;63:420–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Chomette G, Auriol M, Baubion D, de Frejacques C. Non-bacterial thrombotic endocarditis. Autopsy study, clinico-pathological correlations. Ann Med Interne (Paris). 1980;131(7):443–7.Google Scholar
  31. 31.
    Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120(7):636–42.CrossRefPubMedGoogle Scholar
  32. 32.
    Bathina JD, Daher IN, Plana JC, Durand J-B, Yusuf SW. Acute myocardial infarction associated with nonbacterial thrombotic endocarditis. Tex Heart Inst J. 2010;37(2):208–12.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Kim HS, Suzuki M, Lie JT, Titus JL. Nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation (DIC): autopsy study of 36 patients. Arch Pathol Lab Med. 1977;101(2):65–8.PubMedGoogle Scholar
  34. 34.
    Delahaye JP, Poncet P, Malquarti V, Beaune J, Gare JP, Mann JM. Cerebrovascular accidents in infective endocarditis: role of anticoagulation. Eur Heart J. 1990;11(12):1074–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Tornos P, Almirante B, Mirabet S, Permanyer G, Pahissa A, Soler-Soler J. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med. 1999;159(5):473–5.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Syed Wamique Yusuf
    • 1
  • Steven C. Napierkowki
    • 1
  • Jose Banchs
    • 1
  • Javier A. Adachi
    • 2
  • Saamir A. Hassan
    • 1
  1. 1.Department of CardiologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of Infectious Diseases, Infection Control and Employee HealthUniversity of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations